The rapidly escalating price of new cancer treatments threatens to erase the value from value-based cancer care. Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, of Cleveland Clinic Cancer Center discusses how to approach this complex problem.

Care paths are an important component of value-based treatment. Cleveland Clinic Cancer Center leaders worried that physicians might resent the standardization, but in fact they welcomed it.

In a value-based care program, “translational research has to be front and center in what we do,” says Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP of Cleveland Clinic Cancer Center. So does listening to patients about the treatment outcomes they value.

To reduce anxiety and improve outcomes, cancer patients need help to navigate the treatment process, and consistent information about their care. Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, explains the importance of care coordination at Cleveland Clinic Cancer Center.

Shortening patients’ wait between cancer diagnosis and treatment is a complicated but essential step in providing value-based care. Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, describes Cleveland Clinic Cancer Center’s approach to the problem, which uses business intelligence tools.

As healthcare systems shift to value-based care, providers are examining all facets of their patients’ experience and are exploring how to quantify and deliver what matters most. Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, discusses how Cleveland Clinic Cancer Center defines value-based cancer care and tackles the challenges to improving it.